Royal Bank of Canada
INBX

Royal Bank of Canada’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Royal Bank of Canada’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,324
Closed -$46K – 7822
2024
Q1 		$46K Sell
1,324
-14,669
-92% -$535K ﹤0.01% 5580
2023
Q4 		$607K Buy
15,993
+10,812
+209% +$232K ﹤0.01% 4105
2023
Q3 		$95K Buy
5,181
+1,821
+54% +$38.1K ﹤0.01% 5419
2023
Q2 		$87K Buy
3,360
+1,135
+51% +$26.5K ﹤0.01% 5447
2023
Q1 		$41K Sell
2,225
-2,899
-57% -$67.4K ﹤0.01% 5727
2022
Q4 		$126K Buy
5,124
+4,384
+592% +$129K ﹤0.01% 5280
2022
Q3 		$13K Buy
740
+191
+35% +$3.44K ﹤0.01% 6327
2022
Q2 		$6K Sell
549
-1,551
-74% -$22.8K ﹤0.01% 6622
2022
Q1 		$47K Sell
2,100
-4,053
-66% -$103K ﹤0.01% 6152
2021
Q4 		$269K Buy
6,153
+3,146
+105% +$126K ﹤0.01% 5048
2021
Q3 		$100K Buy
3,007
+691
+30% +$21K ﹤0.01% 5707
2021
Q2 		$65K Buy
2,316
+1,178
+104% +$24.5K ﹤0.01% 5865
2021
Q1 		$23K Buy
1,138
+562
+98% +$16.4K ﹤0.01% 6360
2020
Q4 		$19K Buy
576
+191
+50% +$5.08K ﹤0.01% 6099
2020
Q3 		$7K Buy
+385
New +$6.98K ﹤0.01% 6073

Other funds holding INBX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Royal Bank of Canada's INBX Position: Q2 2024 in Review

Royal Bank of Canada sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 1,324 shares — an estimated $46K sold.

Royal Bank of Canada first reported a position in INBX in Q3 2020 and held it in 15 quarters. The position peaked at $607K in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • Royal Bank of Canada reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 1,324 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $46K.
  • Royal Bank of Canada first reported a position in Inhibrx, Inc. Common Stock in Q3 2020 and held it in 15 quarters.
  • Royal Bank of Canada's Inhibrx, Inc. Common Stock position peaked at $607K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Royal Bank of Canada's 13F filing for Q2 2024, filed 14 Aug 2024.